Evidence map›Paper›PMID 33746108›Full record

ArticleTranslational research : the journal of laboratory and clinical medicine2021

Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises.

Lynn D Wenger, Alex H Kral, Ricky N Bluthenthal, Terry Morris, Lee Ongais, Barrot H Lambdin

Open access · bronzeAbstract read
In one paragraph

Article in Translational research : the journal of laboratory and clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
7.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Program Director Reports of COVID-19 Lockdown-Driven Service Changes in Community-Based STI Clinics and Syringe Services Programs in the Southeastern U.S.AIDS education and prevention : official publication of the International Society for AIDS Education · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lynn D WengerRTI International, Berkeley, California. Electronic address: lynndee@rti.org.
Alex H KralRTI International, Berkeley, California.
Ricky N BluthenthalUniversity of Southern California, Keck School of Medicine, Los Angeles, California.
Terry MorrisRTI International, Berkeley, California.
Lee OngaisRTI International, Berkeley, California.
Barrot H LambdinRTI International, Berkeley, California.
RTI International · USUniversity of Southern California · US

Funding

Preventing Opioid Overdose Mortality in the United StatesR01DA046867 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI LAMBDIN, BARROT HOPKINS · 2018 to 2020
$1.4M
NIDA NIH HHS R01 DA046867
6 · The paper itself

Abstract

As COVID-19 accelerated throughout 2020, syringe service programs (SSPs) faced challenges necessitating programmatic adaptations to prevent overdose deaths while simultaneously keeping workers and participants safe from COVID-19. We used qualitative methods to gain an understanding of the social context within which SSPs are operating during the COVID-19 pandemic. We conducted 36 in-depth interviews with program representatives from 18 programs and used the Exploration, Preparation, Implementation, Sustainment (EPIS) implementation framework to guide data analysis. We focused on 3 of the 4 EPIS constructs: Outer context, inner context, and innovation factors. Our data indicate that responding to the pandemic led to innovations in service delivery such as secondary and mail-based distribution, adoption of telemedicine for enrolling participants in medications for opioid use disorder (MOUD) and use of virtual training platforms for overdose prevention. We found high levels of staff and volunteer commitment, which was a cornerstone to the success of these innovations. We observed that many SSPs were short-staffed because of their commitment to safety, and some lost current funding as well as opportunities for future funding. Despite minimal staffing and diminished funding, SSPs innovated at an accelerated pace. To ensure the sustainability of these new approaches, a supportive external context (federal, state, and local policies and funding) is needed to support the development of SSPs' inner contexts (organizational characteristics, characteristics of individuals) and sustainment of the innovations achieved regarding delivery of naloxone and MOUD.

Indexed as

SyringesCOVID-19HumansOpiate OverdoseOrganizational InnovationUnited StatesCDC = U.S. Centers for Disease Control and PreventionCOVID-19 = Novel coronavirus 2019EPIS = Exploration, Preparation, Implementation, and Sustainment implementation frameworkHCV = hepatitis C virusMOUD = medications for opioid use disorderOENDα = overdose education and naloxone distributionPWUD = people who use drugsSSP = syringe service program

Identifiers

PMID33746108
PMCPMC8217165
OpenAlexW3136831652

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.